Discontinued — last reported Q4 '25

Investing

Acquisitions

Year-over-year, this metric grew by 103.1%, from $103.17M to $209.56M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -16.9% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: acquisitions

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.58B-$1.18M$119.55M$0.00$0.00$190.32M$239.39M$99.27M$0.00$147.39M$1.99B$0.00$0.00$0.00$117.51M$103.17M$945.00K$829.13M$0.00$209.56M
QoQ Change-100.1%>999%-100.0%+25.8%-58.5%-100.0%>999%-100.0%-12.2%-99.1%>999%-100.0%
YoY Change-100.0%>999%+100.2%-22.6%+731.8%-100.0%-100.0%-94.1%-100.0%+103.1%
Range-$1.18M$1.99B
CAGR-34.6%
Avg YoY Growth>999%
Median YoY Growth-58.3%

Frequently Asked Questions

What is Ametek's acquisitions?
Ametek (AME) reported acquisitions of $209.56M in Q1 2026.
How has Ametek's acquisitions changed year-over-year?
Ametek's acquisitions increased by 103.1% year-over-year, from $103.17M to $209.56M.
What is the long-term trend for Ametek's acquisitions?
Over 4 years (2021 to 2025), Ametek's acquisitions has grown at a -16.9% compound annual growth rate (CAGR), from $1.96B to $933.24M.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.